A biopharmaceutical company focused on the research, development and commercialization of products targeting the medical challenge of resistance and non-response to current treatment options for fungal infections, bacterial infections and cancer.
Lead Underwriter
Cowen and Company, LLC,Guggenheim Securities, LLC
Co-Managers
BTIG, LLC,Robert W. Baird & Co. Incorporated,SunTrust Robinson Humphrey, Inc
